广泛梗死卒中取栓可能无益且增加出血风险
这项回顾性多中心研究比较了基于CT筛选的广泛基线梗死(ASPECTS≤5)前循环卒中患者接受血管内治疗(EVT)与最佳药物治疗的效果。配对后248例患者中,EVT组与药物治疗组良好功能结局率无显著差异(27.4% vs 25%,P=0.665),但EVT组死亡率和症状性颅内出血显著更高。首次或第二次完全再通的患者可能获益。
要点
- EVT组与药物治疗组90天良好功能结局率无显著差异。
- EVT组死亡率和症状性颅内出血显著高于药物治疗组。
- 首次或第二次完全再通者可能从EVT获益。
核心结论
- 在日常临床实践中,对CT筛选的低ASPECTS前循环卒中患者,EVT可能无益且增加出血和死亡风险,尤其是老年人。
- 首次或第二次完全再通似乎显示EVT的临床获益,提示低ASPECTS亚组的脆弱性。
研究设计与样本
- 回顾性、多中心研究,比较EVT与最佳药物治疗基于CT选择的广泛基线梗死(ASPECTS≤5)前循环卒中患者。
- 患者来自德国卒中登记处和3个三级卒中中心,经1:1配对后共248例患者按治疗组比较。
主要发现
- EVT组良好功能结局(mRS≤3)率为27.4%,药物治疗组为25%(P=0.665)。
- EVT组死亡率43.5% vs 药物治疗组28.9%(P=0.025),症状性颅内出血16.1% vs 5.6%(P=0.008)。
- 高龄(调整OR 1.08 [95%CI 1.05–1.10],P<0.001)和症状性颅内出血(调整OR 6.35 [95%CI 2.08–19.35],P<0.001)与极差结局独立相关。
- 失败和部分再通(mTICI 0/1–2a)组良好功能结局率最低(约15%)。
- 完全再通(mTICI 3)且再通尝试≤2次的患者获益最大(mRS≤3:42.3%,P=0.074)。
关键数值与推荐
- 广泛基线梗死定义为Alberta卒中项目早期CT评分(ASPECTS)≤5。
- 良好功能结局定义为90天改良Rankin量表(mRS)评分≤3。
- 极差结局定义为90天mRS评分≥5。
- 血管造影结局采用改良脑梗死溶栓(mTICI)量表评估。
临床怎么用
- 对于CT筛选的低ASPECTS(≤5)前循环卒中患者,EVT可能不改善功能结局且增加出血和死亡风险。
- 在考虑EVT时,应关注再通尝试次数,首次或第二次完全再通可能带来临床获益。
局限性
- 回顾性研究设计可能引入选择偏倚。
- 样本量有限(配对后248例),部分亚组分析效力不足。
- 结果基于CT筛选的低ASPECTS患者,推广需谨慎。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND PURPOSE: This study evaluates the benefit of endovascular treatment (EVT) for patients with extensive baseline stroke compared with best medical treatment. METHODS: This retrospective, multicenter study compares EVT and best medical treatment for computed tomography (CT)–based selection of patients with extensive baseline infarcts (Alberta Stroke Program Early CT Score ≤5) attributed to anterior circulation stroke. Patients were selected from the German Stroke Registry and 3 tertiary stroke centers. Primary functional end points were rates of good (modified Rankin Scale score of ≤3) and very poor outcome (modified Rankin Scale score of ≥5) at 90 days. Secondary safety end point was the occurrence of symptomatic intracerebral hemorrhage. Angiographic outcome was evaluated with the modified Thrombolysis in Cerebral Infarction Scale. RESULTS: After 1:1 pair matching, a total of 248 patients were compared by treatment arm. Good functional outcome was observed in 27.4% in the EVT group, and in 25% in the best medical treatment group (P=0.665). Advanced age (adjusted odds ratio, 1.08 [95% CI, 1.05–1.10], P<0.001) and symptomatic intracerebral hemorrhage (adjusted odds ratio, 6.35 [95% CI, 2.08–19.35], P<0.001) were independently associated with very poor outcome. Mortality (43.5% versus 28.9%, P=0.025) and symptomatic intracerebral hemorrhage (16.1% versus 5.6%, P=0.008) were significantly higher in the EVT group. The lowest rates of good functional outcome (≈15%) were observed in groups of failed and partial recanalization (modified Thrombolysis in Cerebral Infarction Scale score of 0/1–2a), whereas patients with complete recanalization (modified Thrombolysis in Cerebral Infarction Scale score of 3) with recanalization attempts ≤2 benefitted the most (modified Rankin Scale score of ≤3:42.3%, P=0.074) compared with best medical treatment. CONCLUSIONS: In daily clinical practice, EVT for CT–based selected patients with low Alberta Stroke Program Early CT Score anterior circulation stroke may not be beneficial and is associated with increased risk for hemorrhage and mortality, especially in the elderly. However, first- or second-pass complete recanalization seems to reveal a clinical benefit of EVT highlighting the vulnerability of the low Alberta Stroke Program Early CT Score subgroup. REGISTRATION: URL: https://www.clinicaltrials.gov; Unique identifier: NCT03356392.
引用
- Meyer L, Bechstein M, Bester M, et al. Thrombectomy in Extensive Stroke May Not Be Beneficial and Is Associated With Increased Risk for Hemorrhage. Stroke. 2021. PMID: 34470489. doi:10.1161/STROKEAHA.120.033101
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。